A peptide corresponding to the amino-terminal 25 amino acids of the mature vesicular stomatitis virus glycoprotein has recently been shown to be a pH-dependent hemolysin. In the present study, we analyzed smaller constituent peptides and found that the hemnolytic domain resides within the six amino-terminal amino acids. Synthesis of variant peptides indicates that the amino-terminal lysine can be replaced by another positively charged amino acid (arginine) but that substitution with glutamic acid results in the total loss of the hemolytic function. Peptide-induced hemolysis was dependent upon buffer conditions and was inhibited when isotonicity was maintained with mannitol, sucrose, or raffinose. In sucrose, all hemolytic peptides were also observed to mediate hemagglutination. The large 25-amino acid peptide is also a pH-dependent cytotoxin for mammalian cells and appears to effect gross changes in cell permeability. Conservation of the amino terminus of vesicular stomatitis virus and rabies virus suggests that the membrane-destabilizing properties of this domain may be important for glycoprotein function.
A peptide corresponding to the amino-terminal 25 amino acids of the mature vesicular stomatitis virus glycoprotein has recently been shown to be a pH-dependent hemolysin. In the present study, we analyzed smaller constituent peptides and found that the hemnolytic domain resides within the six amino-terminal amino acids. Synthesis of variant peptides indicates that the amino-terminal lysine can be replaced by another positively charged amino acid (arginine) but that substitution with glutamic acid results in the total loss of the hemolytic function. Peptide-induced hemolysis was dependent upon buffer conditions and was inhibited when isotonicity was maintained with mannitol, sucrose, or raffinose. In sucrose, all hemolytic peptides were also observed to mediate hemagglutination. The large 25-amino acid peptide is also a pH-dependent cytotoxin for mammalian cells and appears to effect gross changes in cell permeability. Conservation of the amino terminus of vesicular stomatitis virus and rabies virus suggests that the membrane-destabilizing properties of this domain may be important for glycoprotein function.
Vesicular stomatitis virus (VSV) infects host cells via adsorptive endocytosis (3, 4, 6, 10, 12, 15, 17) . The first phase of this process, viral attachment, represents the interaction of VSV glycoproteins with a limited number (4,000) of saturable "receptors" as well as nonsaturatable binding sites (16) . Rabies virus, a related rhabdovirus, binds to the same saturable cell surface receptor (19) , and the specific binding of both VSV and rabies virus appears to reflect interactions with membrane lipids. VSV binds preferentially to the acidic phospholipid phosphatidylserine (13) . After binding, VSV is rapidly translocated into plasma membrane "coated pits" and then transferred into intracellular vesicles (endosomes). It is believed that the acidification of these endosomes by an ATP-dependent proton pump is responsible for initiating the fusion of viral and cellular membranes. Several findings indicate that membrane fusion is mediated by the VSV glycoprotein (G protein): (i) mammalian cells can be fused by exogeneous VSV under acidic conditions (18) ; (ii) cells expressing cloned G protein are fusogenic at low pH (7, 11) ; and (iii) purified G protein can effect liposome membrane fusion as detected by fluorescence energy transfer and electron microscopy (5). Reflecting its function as a fusogen, G protein (incorporated in liposomes) can hemolyze erythrocytes under acidic conditions (1) . Similarly, peptides correspornding to the amino terminus of G protein can also function as pH-dependent hemolysins (14) . The purpose of this study was to use additional synthetic peptides to further define the hemolytic domain of G protein and to characterize the biological properties of such peptides.
Hemolysis assays were performed with sheep erythrocytes at a concentration of ca. 7 x 108 erythrocytes per ml.
Total hemolysis (in distilled water) produced a spectrophotometric absorbance at 541 nm of 0.50. All hemolysis assays were performed in glass tubes in a volume of 1.0 ml as previously described (14) . Due (14) , it was speculated that the amino terminus of G protein represents an important domain for membrane destabilization and fusion. To further delineate and define the properties of KFT(25), we synthesized several constituent and variant peptides. The composition of these peptides is shown in Fig. 1 . KFT(25) represents the 25-amino acid peptide that was recently shown to be a pH-dependent hemolysin. HNQ (18) represents the carboxy-terminal 18 amino acids, and KFT(6) represents the amino-terminal 6 amino acids of KFT(25). RFT (6) and EFT(6) are modifications of KFT (6) in which the amino-terminal lysine has been changed to either arginine or glutamic acid, respectively. Finally, KFF(6) represents a prototype molecule in which the amino-terminal lysine has been retained but the hydrophobic region consists of a sequence of five phenylalanine molecules. All of the peptides shown in Fig. 1 were tested for their hemolytic activity (Fig. 2) . At pH 5.0, KFT (25) showed a half-maximal response at a concentration of 40 F.M. Interestingly, the first six amino acids of this peptide, KFT(6), were sufficient to act as a hemolysin. The shorter peptide, however, was more potent than the original KFT (25) and showed half-maximal hemolysis at 3 F.M. In contrast to the amino-terminal KFT(6) peptide, the carboxy-terminal peptide, HNQ (18) , showed no hemolytic activity.
The potent hemolytic activity of the short peptide, KFT(6), was somewhat surprising and was further characterized by a study of the properties of two additional peptides. RFT (6) and EFT(6) represent variants of KFT (6) (9) . KFT(25), HNQ (18) , and KFT (6) represent peptides of the glycoprotein of VSV (Indiana, San Juan strain). RFT(6), EFT (6) , and KFF (6) represent modifications of KFT (6) acidic amino acid (glutamic acid) forms a neutral amino terminus and results in the complete loss of hemolytic function. To determine whether hemolysis was a consequence of a short hydrophobic sequence coupled to a positively charged amino acid, we assayed the activity of another peptide, KFF(6), containing an amino-terminal lysine followed by five phenylalanine molecules. This constructed peptide did exhibit some hemolytic activity, but only at relatively high concentrations (half-maximal at 300 FLM). KFT(25) and KFT(6) differ in their pH dependence. Although KFT(6) probably represents the domain of KFT(25) which mediates hemolysis, these two peptides displayed quite different profiles of hemolysis when pH was varied (Fig. 3) . As described previously (14) , KFT(25) is most active at acidic pH values (less than 6.0). KFT(6), however, shows little variation of activity at pH values ranging from 5.0 to 7.0.
Peptide hemolytic activity is dependent upon buffer conditions. KFT(25) lyses erythrocytes quickly in buffers which are made iso-osmotic with small ionic molecules such as NaCl or RbCl (Fig. 4) . However, lysis is delayed when iso-osmotic conditions are achieved with nonionic molecules such as mannitol, sucrose, or raffinose. This inhibition of hemolysis appears to result from a decrease in the rate of hemolysis since the extent of hemolysis is unaffected (data not shown). This would suggest that nonionic buffers are inhibiting the process of hemolysis rather than the binding of peptide to erythrocyte. Studies on the hemagglutination activities of these peptides also indicate that nonionic buffers do not inhibit peptide-erythrocyte binding (see below). Similar findings were also observed with KFT(6).
Hemolytic peptides are also hemagglutinins. When KFT(25) and KFT(6) were added to erythrocytes in sucrose, hemolysis was inhibited but the erythrocytes were observed to agglutinate ( Fig. SB and C) . Hemagglutination could also be observed in NaCl buffers, but at pH 5.0 this event was transient and quickly progressed to hemolysis. Nonhemolytic peptides such as HNQ (18) and EFT(6) were nonhemagglutinating under all conditions tested ( Fig. 5D and E) . Hemagglutination by KFT(25) could be performed in either sucrose or NaCI if the pH was maintained at 7.4. Under such conditions, KFT(25) had a greater hemagglutinating activity in sucrose than in NaCl. KFT caused hemagglutination at 4 p.g/ml in sucrose but required 125 p.g/ml in NaCl. Hemagglutination per se is not sufficient to initiate pH-dependent hemolysis. For example, the addition of polylysine (500 and 1,000 pLg/ml) to the hemolysis assay caused massive hemagglutination at pH 5.0 but no hemolysis.
Protease treatment of erythrocytes does not affect peptideinduced hemolysis. VSV G protein is believed to function as a fusogen via its interaction with membrane phospholipids Comparison of the hemolytic activities of the synthetic peptides. Peptide stock solutions (10 to 100 mM in distilled water) were diluted appropriately into the hemolysis assay, and the release of hemoglobin was measured after 10 min at 37°C. Peptides EFT(6) and KFF (6) were dissolved in dimethyl sulfoxide. Control assays with dimethyl sulfoxide showed no hemolysis. KFT(6) was the most potent hemolysin (half-maximal hemolysis at 3 F.M).
(5). Although we believe that the KFT(6) and KFT(25) peptides may be reflecting a membrane-destabilizing function of G protein, there is no direct evidence that these peptides interact with lipids. As a preliminary attempt to discern whether membrane proteins of the sheep erythrocyte might be acting as the binding site for these peptides, we incubated sheep erythrocytes with proteinase K (10 to 200 ,ug/ml) or trypsin (10 to 200 ,ug/ml) for 30 min at 37°C. The erythrocytes were washed and used in the standard hemolysis assay. There was no difference in sensitivity to hemolysis between control erythrocytes and those treated with proteases (data not shown).
Hemolytic peptides are cytotoxic. To evaluate whether the hemolytic peptides could also interact with the membranes of nucleated cells, we added KFT(25) to Vero (monkey kidney) cells grown in tissue culture. The pH of the buffer was adjusted to either 7.4 or 5.5, and membrane permeability to trypan blue was assayed at different times of incubation at 37°C (Fig. 6 ). Cells exposed to KFT(25) at pH 5.5 showed a dose-dependent increase in permeability to trypan blue assayed after 20 min of exposure. Control cells at pH 5.5 showed no staining with trypan blue. In addition, cells exposed to KFT(25) at pH 7.4 also showed no staining. This rapid cytotoxic effect was accompanied by several discernible morphological changes (Fig. 7) . Soon after 100 ,uM KFT(25) was added at pH 5.5, Vero cells swelled and lost their distinct plasma membrane borders. Nuclei became (25) were performed in different iso-osmotic buffers at pH 5.0. Buffer compositions were as follows: NaCl (150 mM NaCl, 10 mM morpholineethanesulfonic acid [MES] buffer; pH 5.0); RbCl (150 mM RbCl, 10 mM MES buffer; pH 5.0); NaCl/mannitol (25 mM NaCl, 250 mM mannitol, 10 mM MES buffer; pH 5.0); NaCI/sucrose (25 mM NaCl, 250 mM sucrose, 10 mM MES buffer; pH 5.0); NaCl/raffinose (25 mM NaCl, 250 mM raffinose, 10 mM MES buffer; pH 5.0). NaCl was added to mannitol, sucrose, and raffinose buffers to maintain the ionic environment at 50 mM and to avoid inducing leakage of K+ from erythrocytes. Identical findings were obtained with 300 mM mannitol, sucrose, and raffinose without NaCl.
enlarged and cleared and nucleolar structure was obscured \ (Fig. 7B) . However, no evidence of cell fusion was ob-KFTM6J served. Electron microscopy confirmed gross vacuolization of the cell cytoplasm, nuclear swelling, loss of nuclear matrix, but retention of the plasma membrane bilayer structure (data not shown). Vero cells at pH 5.5 (Fig. 7A) or at pH 7.4 with 100 ,uM KFT(25) (Fig. 7C) showed essentially normal morphology. We believe these findings are consistent with the KFT(25) peptide causing profound changes in membrane permeability.
The amino terminus of VSV G protein, whether presented as a 6-or a 25-amino acid peptide, can function as a hemolysin. The mechanism by which these peptides mediate hemolysis is unknown. Previous data demonstrating a lag in the initiation of hemolysis (14), coupled with data in this manuscript showing that sucrose or raffinose buffers inhibit hemolysis, are consistent with a colloid-osmotic type of hemolysis. Presumably, such a mechanism would necessi- KFT(25) tate the formation of membrane defects which would permit only small ions (for example, sodium) to enter the erythrot* cyte. We are currently evaluating the efflux of rubidium ions and hemoglobulin from the erythrocyte to determine whether there is a pre-lytic leak of small ions. It seems very unlikely that single, six-amino acid peptides could form "ion chan- (8) .
An initial attempt to produce a prototype hemolysin, KFF(6), was not successful. This peptide exhibits several of the basic features of KFT(6) and RFT(6): a positively charged (+2) amino terminus followed by a short sequence of hydrophobic amino acids. Compared with KFT(6) or RFT(6), however, this peptide had little hemolytic activity. It is possible that the relatively large phenylalanine side groups prohibited a necessary peptide conformation. Whatever the mode of interaction of peptide with membrane, it appears that decreasing the positive charge of the amino terminus to a neutral state with glutamic acid abolishes its activity. Although this might suggest an ionic interaction with a negatively charged molecule, it is still possible that either a positive or a negative charge would suffice at the amino end.
The conservation of the amino terminus of G protein in the various strains of VSV and in rabies virus suggests that this domain may have an important role in glycoprotein function. If the hemolytic activities observed for the synthesized peptides truly reflect the function of the amino terminus of G protein, then one could speculate that the amino terminus functions in membrane destabilization and consequent fusion. It is not unexpected that the hemolytic peptides are nonfusogenic. For G protein to function as a fusogen, it needs to be anchored in the plasma membrane by its hydrophobic carboxy-terminal region (7) . The hemolytic peptides lack this membrane anchorage and apparently cannot facilitate the necessary mnembrane-membrane interaction to effect fusion.
Direct evidence for the participation of the G protein amino terminus in membrane fusion could be obtained from genetic manipulation of cloned G protein. Several plasmid constructs are now available that express G protein at sufficient levels in mammalian cells to initiate pH-dependent membrane fusion (7, 11) . Selective deletion of the amino end of the mature VSV G protein should permit one to determine whether or to what extent this domain participates in fusion.
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